Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-December 31, 2021) for Pregnancy

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
PregnancyGift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-December 31, 2021) - Behavioral
Eligibility
18 - 35
Female
What conditions do you have?
Select

Study Summary

This trial will estimate the impact of financial access to contraception on a variety of outcomes like childbearing, education, mental health, etc.

Treatment Effectiveness

Study Objectives

6 Primary · 0 Secondary · Reporting Duration: Up to 3 year post-enrollment

100 days from enrollment
Incidence of patients billing for use of any contraception (1 for use of contraception/0 no use of contraception)
Year 1
Incidence of patients billing for long-run acting, reversible contraception (LARC) (0 no use of LARC/1 for use of LARC)
Year 1
Incidence of pregnancy up to 1 year post enrollment
Year 1
Incidence of childbirth up to 1 year post enrollment
Year 3
Incidence of pregnancy up to 3 years post enrollment
Year 3
Incidence of childbirth up to 3 year post enrollment

Trial Safety

Trial Design

2 Treatment Groups

Control Group
1 of 2
Treatment Group
1 of 2

Active Control

Experimental Treatment

5000 Total Participants · 2 Treatment Groups

Primary Treatment: Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-December 31, 2021) · No Placebo Group · N/A

Treatment GroupExperimental Group · 3 Interventions: Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-December 31, 2021), Gift card to be used for contraceptives that is valued at 50% of cost of name-brand IUD (August 26, 2018-March 3, 2019), Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-March 31, 2023) · Intervention Types: Behavioral, Behavioral, Behavioral
Control GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 3 year post-enrollment

Who is running the clinical trial?

National Opinion Research CenterOTHER
10 Previous Clinical Trials
130,883 Total Patients Enrolled
University of MichiganLead Sponsor
1,626 Previous Clinical Trials
6,412,021 Total Patients Enrolled

Eligibility Criteria

Age 18 - 35 · Female Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are biologically female and fecund.\n